Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate

Clinical trial NCT04511702 · COMPLETED

Trial details

NCT number: NCT04511702
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Uncontrolled Gout Gout Uncontrolled Gout

Start date: 2020-10-02
Primary completion: 2024-01-18
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.